Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

4.130

-0.160 (-3.73%)

At close: Aug 24, 2026, 4:00 PM EDT

4.190

+0.060 (1.45%)

Pre-market: Aug 25, 2026, 8:38 AM EDT

Ironwood Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	129.87	24.02	0.88	-1,002	175.07	528.45
Depreciation & Amortization	1.84	1.88	2.01	1.58	1.42	1.52
Loss (Gain) From Sale of Assets	0	0.09	0.08	-	0	0.09
Asset Writedown & Restructuring Costs	-	-	-	1,095	-	-
Stock-Based Compensation	14.32	17.25	29.85	32.01	27.05	22.28
Other Operating Activities	63.8	44.16	71.55	45.36	67.41	-308.18
Change in Accounts Receivable	-26.56	35.15	47.24	0.92	7.99	7.71
Change in Accounts Payable	0.88	6.2	-20.21	12.38	-8.12	-2.64
Change in Other Net Operating Assets	1.41	-1.7	-27.85	-2.03	2.94	12.66
Operating Cash Flow	185.56	127.04	103.55	183.43	273.76	261.9
Operating Cash Flow Growth	518.83%	22.69%	-43.55%	-33.00%	4.53%	55.12%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-0	-0.03	-0.14	-0.27	-0.14	-0.27
Cash Acquisitions	-	-	-	-1,026	-	-
Investing Cash Flow	-0	-0.03	-0.14	-1,026	-0.14	-0.27

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Issued	-	-	150	400	-	-
Long-Term Debt Repaid	-	-	-265	-100	-120.7	-
Net Debt Issued (Repaid)	-200	-	-115	300	-120.7	-
Issuance of Common Stock	0.43	0.22	11.01	6.36	9.54	19.58
Repurchase of Common Stock	-	-	-0.74	-	-126.39	-24.13
Other Financing Activities	-	-	-2.25	-29.2	-	-
Financing Cash Flow	-199.58	0.22	-106.97	277.16	-237.55	-4.55

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Foreign Exchange Rate Adjustments	0.3	-0.33	-0.03	-0.05	-	-
Net Cash Flow	-13.73	126.9	-3.6	-565.78	36.07	257.08

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	185.55	127.01	103.41	183.15	273.63	261.63
Free Cash Flow Growth	519.84%	22.82%	-43.54%	-33.06%	4.58%	56.67%
Free Cash Flow Margin	47.66%	42.89%	29.43%	41.37%	66.64%	63.23%
Free Cash Flow Per Share	1.12	0.78	0.65	1.18	1.47	1.59
Levered Free Cash Flow	121.83	111.69	80.71	204.13	161.46	170.05
Unlevered Free Cash Flow	142.25	132.16	101.51	217.5	166.21	189.52

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash Interest Paid	30.33	30.33	32.56	13.55	5.75	7.22
Cash Income Tax Paid	3.54	3.54	8.41	9.95	4.62	3.45
Change in Working Capital	-24.27	39.65	-0.82	11.28	2.82	17.73

SEC Filings: 10-K · 10-Q